Multicenter Experience with the Pipeline Flex and Vantage with Shield Technology for Intracranial Aneurysm Treatment

References

1. 1.↵
   1. Kallmes DF,
   2. Hanel R,
   3. Lopes D, et al

   . International retrospective study of the Pipeline Embolization Device: a multicenter aneurysm treatment study. AJNR Am J Neuroradiol 2015;36:108–15 doi:10.3174/ajnr.A4111 pmid:25355814

   Abstract/FREE Full Text
2. 2.↵
   1. Brinjikji W,
   2. Lanzino G,
   3. Cloft HJ, et al

   . Risk factors for ischemic complications following Pipeline Embolization Device treatment of intracranial aneurysms: results from the intrePED study. AJNR Am J Neuroradiol 2016;37:1673–78 doi:10.3174/ajnr.A4807 pmid:27102308

   Abstract/FREE Full Text
3. 3.↵
   1. Kühn AL,
   2. Gounis MJ,
   3. Puri AS

   . Introduction: history and development of flow diverter technology and evolution. Neurosurgery 2020;86:S3–10 doi:10.1093/neuros/nyz307 pmid:31838534

   CrossRefPubMed
4. 4.↵
   1. Maragkos GA,
   2. Dmytriw AA,
   3. Salem MM, et al

   . Overview of different flow diverters and flow dynamics. Neurosurgery 2020;86:S21–34 doi:10.1093/neuros/nyz323 pmid:31838536

   CrossRefPubMed
5. 5.↵
   1. Colby GP,
   2. Lin L-M,
   3. Caplan JM, et al

   . Immediate procedural outcomes in 44 consecutive Pipeline Flex cases: the first North American single-center series. J Neurointerv Surg 2016;8:702–09 doi:10.1136/neurintsurg-2015-011894 pmid:26136500

   Abstract/FREE Full Text
6. 6.↵
   1. Martínez-Galdámez M,
   2. Lamin SM,
   3. Lagios KG, et al

   . Treatment of intracranial aneurysms using the Pipeline Flex Embolization Device with Shield Technology: angiographic and safety outcomes at 1-year follow-up. J Neurointerv Surg 2019;11:396–99 doi:10.1136/neurintsurg-2018-014204 pmid:30262655

   Abstract/FREE Full Text
7. 7.↵
   1. Starke RM,
   2. Thompson J,
   3. Pagani A, et al

   . Preclinical safety and efficacy evaluation of the Pipeline Vantage Embolization Device with Shield Technology. J Neurointerv Surg 2020;12:981–86 doi:10.1136/neurintsurg-2020-016043 pmid:32487767

   Abstract/FREE Full Text
8. 8.↵
   1. de Villiers L,
   2. do Nascimento VC,
   3. Domitrovic L, et al

   . Vanguard Study: initial experience with the new fourth generation Pipeline Vantage Flow Diverter (PVFD)—6-month results, technical and clinical considerations. J Neurointerv Surg 2024 January 3 [Epub ahead of print] doi:10.1136/jnis-2023-021182 pmid:38171607

   Abstract/FREE Full Text
9. 9.↵
   1. Booth TC,
   2. Bassiouny A,
   3. Lynch J, et al

   . Outcome study of the Pipeline Vantage Embolization Device (second version) in unruptured (and ruptured) aneurysms (PEDVU (R) study). J Neurointerv Surg 2023 December 9 [Epub ahead of print] doi:10.1136/jnis-2023-020754 pmid:38071557

   CrossRefPubMed
10. 10.↵
    1. Sciacca S,
    2. Bassiouny A,
    3. Mansoor N, et al

    . Early Outcomes of the Pipeline Vantage Flow Diverter: a multicentre study. Clin Neuroradiol 2023;33:887–96 doi:10.1007/s00062-023-01314-x pmid:37378843

    CrossRefPubMed
11. 11.↵
    1. Trivelato FP,
    2. Wajnberg E,
    3. Rezende MT, et al

    . Safety and effectiveness of the Pipeline Flex Embolization Device with Shield Technology for the treatment of intracranial aneurysms: midterm results from a multicenter study. Neurosurgery 2020;87:104–11 doi:10.1093/neuros/nyz356 pmid:31504821

    CrossRefPubMed
12. 12.↵
    1. Atasoy D,
    2. Kandasamy N,
    3. Hart J, et al

    . Outcome study of the Pipeline Embolization Device with Shield Technology in unruptured aneurysms (PEDSU). AJNR Am J Neuroradiol 2019;40:2094–101 doi:10.3174/ajnr.A6314 pmid:31727754

    Abstract/FREE Full Text
13. 13.↵
    1. Martínez-Galdámez M,
    2. Lamin SM,
    3. Lagios KG, et al

    . Periprocedural outcomes and early safety with the use of the Pipeline Flex Embolization Device with Shield Technology for unruptured intracranial aneurysms: preliminary results from a prospective clinical study. J Neurointerv Surg 2017;9:772–76 doi:10.1136/neurintsurg-2016-012896 pmid:28223428

    Abstract/FREE Full Text
14. 14.↵
    1. Kallmes DF,
    2. Brinjikji W,
    3. Cekirge S, et al

    . Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms: a pooled analysis of 3 large studies. J Neurosurg 2017;127:775–80 doi:10.3171/2016.8.JNS16467 pmid:27791519

    CrossRefPubMed
15. 15.↵
    1. Kallmes DF,
    2. Brinjikji W,
    3. Boccardi E, et al

    . Aneurysm study of Pipeline in an observational registry (ASPIRe). Interv Neurol 2016;5:89–99 doi:10.1159/000446503 pmid:27610126

    CrossRefPubMed
16. 16.↵
    1. Guimaraens L,
    2. Saldaña J,
    3. Vivas E, et al

    . Flow diverter stents for endovascular treatment of aneurysms: a comparative study of efficacy and safety between FREDX and FRED. J Neurointerv Surg 2024 January 16 [Epub ahead of print] doi:10.1136/jnis-2023-021103 pmid:38228386

    Abstract/FREE Full Text
17. 17.↵
    1. Bechan R,
    2. Sprengers M,
    3. Majoie C, et al

    . Stent-assisted coil embolization of intracranial aneurysms: complications in acutely ruptured versus unruptured aneurysms. AJNR Am J Neuroradiol 2016;37:502–07 doi:10.3174/ajnr.A4542 pmid:26405089

    Abstract/FREE Full Text
18. 18.↵
    1. Chalouhi N,
    2. Jabbour P,
    3. Singhal S, et al

    . Stent-assisted coiling of intracranial aneurysms: predictors of complications, recanalization, and outcome in 508 cases. Stroke 2013;44:1348–53 doi:10.1161/STROKEAHA.111.000641 pmid:23512976

    Abstract/FREE Full Text
19. 19.↵
    1. Chalouhi N,
    2. Tjoumakaris S,
    3. Gonzalez L, et al

    . Coiling of large and giant aneurysms: complications and long-term results of 334 cases. AJNR Am J Neuroradiol 2014;35:546–52 doi:10.3174/ajnr.A3696 pmid:23945229

    Abstract/FREE Full Text
20. 20.↵
    1. Döring K,
    2. Aburub A,
    3. Krauss JK, et al

    . Early clinical experience with the new generation Pipeline Vantage flow diverter in the treatment of unruptured saccular aneurysms using short-term dual antiplatelet therapy. Interv Neuroradiol 2023 October 5 [Epub ahead of print] doi:10.1177/15910199231205047 pmid:37796761

    CrossRefPubMed
21. 21.↵
    1. Bender MT,
    2. Colby GP,
    3. Lin LM, et al

    . Predictors of cerebral aneurysm persistence and occlusion after flow diversion: a single-institution series of 445 cases with angiographic follow-up. J Neurosurg 2018;130:259–67 doi:10.3171/2017.11.JNS171738 pmid:29600915

    CrossRefPubMed
22. 22.↵
    1. Trivelato FP,
    2. Abud DG,
    3. Ulhôa AC, et al

    . Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms. Stroke 2019;50:2351–58 doi:10.1161/STROKEAHA.119.025407 pmid:31288675

    CrossRefPubMed
23. 23.↵
    1. Pierot L,
    2. Soize S,
    3. Cappucci M, et al

    . Surface-modified flow diverter p48-MW-HPC: preliminary clinical experience in 28 patients treated in two centers. J Neuroradiol 2021;48:195–99 doi:10.1016/j.neurad.2020.11.006 pmid:33340638

    CrossRefPubMed